The chemical class denoted as UBB Inhibitors encompasses a group of compounds intricately designed to selectively target the molecular entity UBB, also known as Ubiquitin B. Ubiquitin is a small protein that plays a pivotal role in the post-translational modification of other proteins, marking them for degradation by the proteasome or influencing various cellular processes. UBB is one of the multiple isoforms of ubiquitin, and while ubiquitin itself is well-established in cellular regulatory networks, the distinct functions and regulatory mechanisms of UBB are subjects of ongoing research within the field of molecular biology. Inhibitors within the UBB Inhibitors class are meticulously engineered molecules with the primary goal of modulating the activity or function of UBB, thereby inducing an inhibitory effect. Researchers in this field utilize a multifaceted approach, integrating insights from structural biology, medicinal chemistry, and computational modeling to unravel the complex molecular interactions between the inhibitors and the target UBB.
Structurally, UBB Inhibitors are characterized by specific molecular features designed to facilitate selective binding to UBB. This selectivity is crucial to minimize unintended effects on other cellular components, ensuring a focused impact on the intended molecular target. The development of inhibitors within this chemical class involves a comprehensive exploration of structure-activity relationships, optimization of pharmacokinetic properties, and a deep understanding of the molecular mechanisms associated with UBB. As researchers delve deeper into the functional aspects of UBB Inhibitors, the knowledge generated contributes not only to deciphering the specific roles of Ubiquitin B but also to advancing our broader comprehension of cellular protein degradation pathways, ubiquitin-mediated signaling, and the intricate regulatory networks that govern cellular homeostasis. The exploration of UBB Inhibitors stands as a significant avenue for expanding fundamental knowledge in molecular biology and cell physiology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is known to inhibit the transcription of a wide variety of genes and thus could potentially decrease the transcription of the ubiquitin B gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in protein synthesis. Through this, it could potentially decrease the synthesis of ubiquitin B. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase, potentially decreasing mRNA synthesis for ubiquitin B. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Although a proteasome inhibitor, MG132 might indirectly affect the expression of ubiquitin B by altering cellular regulatory mechanisms. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, another proteasome inhibitor, could influence ubiquitin B levels by disrupting the feedback regulation of protein degradation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to inhibit lysosomal function, Chloroquine could affect global gene expression, including that of ubiquitin B, due to altered cellular homeostasis. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that can change chromatin structure, potentially impacting gene expression, including the ubiquitin B gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound can cause DNA demethylation, which may affect transcription of various genes, potentially including ubiquitin B. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-Azacytidine, Decitabine may affect gene expression patterns, potentially including that of ubiquitin B. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
It inhibits protein synthesis, which could lead to a reduction in the levels of ubiquitin B, among other proteins. | ||||||